{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:30:39Z","timestamp":1789587039682,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Emerging evidence suggests that cardiometabolic index (CMI) is closely related to diabetes, hypertension, stroke, cardiovascular disease, and kidney disease, which implies that CMI has the value as an indicator of metabolic diseases. However, data on the relationships between CMI and non-alcoholic fatty liver disease (NAFLD) risks have not been reported. This study is designed to examine the association between CMI and NAFLD in the general population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The current study included 14,251 subjects whose CMI was the product of triglyceride\/high-density lipoprotein cholesterol ratio and waist-to-height ratio. Linear regression was used to analyze the correlation between baseline information and CMI, logistic regression was used to study the relationship between CMI and NAFLD, and subgroup analysis was used to explore potential high-risk groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After adjusted for potential confounding factors, higher CMI was independently associated with NAFLD, in which every additional standard deviation (SD) of CMI increased the risk of NAFLD by 28% (OR 1.28 per SD increase, 95% CI 1.19\u20131.37, <jats:italic>P<\/jats:italic> for trend\u2009&lt;\u20090.0001). There were also significant differences in CMI-related NAFLD risk among different ages and genders, in which the CMI-related NAFLD risk in young people was significantly higher than that in other age groups (OR\u2009=\u20092.63 per SD increase for young people, OR\u2009=\u20091.38 per SD increase for young and middle-aged people, OR\u2009=\u20091.18 per SD increase for middle-aged and elderly people; OR\u2009=\u20091.14 per SD increase for elderly people, <jats:italic>P<\/jats:italic> for interaction\u2009=\u20090.0010), and the CMI-related NAFLD risk in women was significantly higher than that in men (OR\u2009=\u20091.58 per SD increase for women, OR\u2009=\u20091.26 per SD increase for men, <jats:italic>P<\/jats:italic> for interaction\u2009=\u20090.0045).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Current studies have found that after excluding potential confounding factors, higher CMI in the general population is independently associated with NAFLD risk.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02099-y","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T17:02:53Z","timestamp":1642006973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiawang","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"2099_CR1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease: a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"2099_CR2","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1042\/CS20200446","volume":"134","author":"L Zhang","year":"2020","unstructured":"Zhang L, She ZG, Li H, Zhang XJ. Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis. Clin Sci (Lond). 2020;134:1775\u201399.","journal-title":"Clin Sci (Lond)"},{"key":"2099_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"2099_CR4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65:1017\u201325.","journal-title":"Metabolism"},{"key":"2099_CR5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69:896\u2013904.","journal-title":"J Hepatol"},{"key":"2099_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u201333.","journal-title":"Hepatology"},{"key":"2099_CR7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62:1148\u201355.","journal-title":"J Hepatol"},{"key":"2099_CR8","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.3748\/wjg.v22.i43.9488","volume":"22","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Milic S, Turk Wensveen T, Grgic I, Jakopcic I, Stimac D, et al. Nonalcoholic fatty liver disease: a multisystem disease? World J Gastroenterol. 2016;22:9488\u2013505.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"2099_CR9","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(Suppl 1):S47-64.","journal-title":"J Hepatol"},{"key":"2099_CR10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","volume":"35","author":"MT Long","year":"2015","unstructured":"Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol. 2015;35:1284\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2099_CR11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65:1109\u201323.","journal-title":"Metabolism"},{"key":"2099_CR12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"key":"2099_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12944-019-0986-7","volume":"18","author":"N Fan","year":"2019","unstructured":"Fan N, Peng L, Xia Z, Zhang L, Song Z, Wang Y, et al. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 2019;18:39.","journal-title":"Lipids Health Dis"},{"key":"2099_CR14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, et al. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 2016;36:713\u201320.","journal-title":"Liver Int"},{"key":"2099_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.metabol.2009.07.027","volume":"59","author":"SJ Kim-Dorner","year":"2010","unstructured":"Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism. 2010;59:299\u2013304.","journal-title":"Metabolism"},{"key":"2099_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1747-0080.12520","volume":"76","author":"\u017d Tomas","year":"2019","unstructured":"Tomas \u017d, \u0160kari\u0107-Juri\u0107 T, Zajc Petranovi\u0107 M, Jal\u0161ovec M, Raji\u0107 \u0160ikanji\u0107 P, Smolej NN. Waist to height ratio is the anthropometric index that most appropriately mirrors the lifestyle and psychological risk factors of obesity. Nutr Diet. 2019;76:539\u201345.","journal-title":"Nutr Diet"},{"key":"2099_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275\u201386.","journal-title":"Obes Rev"},{"key":"2099_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.archger.2016.03.021","volume":"65","author":"MM Corr\u00eaa","year":"2016","unstructured":"Corr\u00eaa MM, Thum\u00e9 E, De Oliveira ER, Tomasi E. Performance of the waist-to-height ratio in identifying obesity and predicting non-communicable diseases in the elderly population: a systematic literature review. Arch Gerontol Geriatr. 2016;65:174\u201382.","journal-title":"Arch Gerontol Geriatr"},{"key":"2099_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12876-021-01824-3","volume":"21","author":"G Sheng","year":"2021","unstructured":"Sheng G, Xie Q, Wang R, Hu C, Zhong M, Zou Y. Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterol. 2021;21:239.","journal-title":"BMC Gastroenterol"},{"key":"2099_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cca.2014.08.042","volume":"438","author":"I Wakabayashi","year":"2015","unstructured":"Wakabayashi I, Daimon T. The, \u201ccardiometabolic index\u201d as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274\u20138.","journal-title":"Clin Chim Acta"},{"key":"2099_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12944-018-0886-2","volume":"17","author":"WR Shi","year":"2018","unstructured":"Shi WR, Wang HY, Chen S, Guo XF, Li Z, Sun YX. Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study. Lipids Health Dis. 2018;17:236.","journal-title":"Lipids Health Dis"},{"key":"2099_CR22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.kjms.2016.10.003","volume":"32","author":"M Dursun","year":"2016","unstructured":"Dursun M, Besiroglu H, Otunctemur A, Ozbek E. Association between cardiometabolic index and erectile dysfunction: a new index for predicting cardiovascular disease. Kaohsiung J Med Sci. 2016;32:620\u20133.","journal-title":"Kaohsiung J Med Sci"},{"key":"2099_CR23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/00325481.2017.1375714","volume":"129","author":"H Wang","year":"2017","unstructured":"Wang H, Chen Y, Guo X, Chang Y, Sun Y. Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China. Postgrad Med. 2017;129:834\u201341.","journal-title":"Postgrad Med"},{"key":"2099_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00325481.2018.1444901","volume":"130","author":"H Wang","year":"2018","unstructured":"Wang H, Chen Y, Sun G, Jia P, Qian H, Sun Y. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgrad Med. 2018;130:325\u201333.","journal-title":"Postgrad Med"},{"key":"2099_CR25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12882-018-1098-8","volume":"19","author":"HY Wang","year":"2018","unstructured":"Wang HY, Shi WR, Yi X, Wang SZ, Luan SY, Sun YX. Value of reduced glomerular filtration rate assessment with cardiometabolic index: insights from a population-based Chinese cohort. BMC Nephrol. 2018;19:294.","journal-title":"BMC Nephrol"},{"key":"2099_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43:139\u201348.","journal-title":"Int J Obes (Lond)"},{"key":"2099_CR27","doi-asserted-by":"publisher","unstructured":"Okamura T, et al. (2019), Data from: ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study, Dryad, Dataset.https:\/\/doi.org\/10.5061\/dryad.8q0p192.","DOI":"10.5061\/dryad.8q0p192"},{"key":"2099_CR28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3350\/cmh.2020.0163","volume":"26","author":"JH Choi","year":"2020","unstructured":"Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26:662\u20139.","journal-title":"Clin Mol Hepatol"},{"key":"2099_CR29","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708\u201315.","journal-title":"Am J Gastroenterol"},{"key":"2099_CR30","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/S1473-3099(16)30082-2","volume":"16","author":"EJA Fitchett","year":"2016","unstructured":"Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, et al. Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16:e202\u201313.","journal-title":"Lancet Infect Dis"},{"key":"2099_CR31","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500\u201324.","journal-title":"Int J Surg"},{"key":"2099_CR32","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75:3313\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"2099_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12944-021-01457-1","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou Y, Zhong L, Hu C, Zhong M, Peng N, Sheng G. LDL\/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. Lipids Health Dis. 2021;20:28.","journal-title":"Lipids Health Dis"},{"key":"2099_CR34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12944-021-01573-y","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou Y, Lan J, Zhong Y, Yang S, Zhang H, Xie G. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. Lipids Health Dis. 2021;20:139.","journal-title":"Lipids Health Dis"},{"key":"2099_CR35","first-page":"6676569","volume":"2021","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wang B, Yuan H, Li X. Triglycerides to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in nonobese middle-aged and elderly population: a cross-sectional study. Int J Endocrinol. 2021;2021:6676569.","journal-title":"Int J Endocrinol"},{"key":"2099_CR36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-014-0146-3","volume":"13","author":"T Du","year":"2014","unstructured":"Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.","journal-title":"Cardiovasc Diabetol"},{"key":"2099_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14943","author":"D Pastori","year":"2021","unstructured":"Pastori D, Pani A, Di Rocco A, Menichelli D, Gazzaniga G, Farcomeni A, et al. Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis. Br J Clin Pharmacol. 2021. https:\/\/doi.org\/10.1111\/bcp.14943.","journal-title":"Br J Clin Pharmacol"},{"key":"2099_CR38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mam.2018.03.001","volume":"64","author":"E Scorletti","year":"2018","unstructured":"Scorletti E, Byrne CD. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action. Mol Aspects Med. 2018;64:135\u201346.","journal-title":"Mol Aspects Med"},{"key":"2099_CR39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20:134.","journal-title":"Lipids Health Dis"},{"key":"2099_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0899-9007(03)00061-3","volume":"19","author":"UG Kyle","year":"2003","unstructured":"Kyle UG, Schutz Y, Dupertuis YM, Pichard C. Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index. Nutrition. 2003;19:597\u2013604.","journal-title":"Nutrition"},{"key":"2099_CR41","doi-asserted-by":"crossref","first-page":"e0243068","DOI":"10.1371\/journal.pone.0243068","volume":"15","author":"Y Zou","year":"2020","unstructured":"Zou Y, Sheng G, Yu M, Xie G. The association between triglycerides and ectopic fat obesity: an inverted U-shaped curve. PLoS ONE. 2020;15:e0243068.","journal-title":"PLoS ONE"},{"key":"2099_CR42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/liv.13993","volume":"39","author":"DJ Cuthbertson","year":"2019","unstructured":"Cuthbertson DJ, Brown E, Koskinen J, Magnussen CG, Hutri-K\u00e4h\u00f6nen N, Sabin M, et al. Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood. Liver Int. 2019;39:1147\u201354.","journal-title":"Liver Int"},{"key":"2099_CR43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.18632\/aging.101221","volume":"9","author":"BK Kennedy","year":"2017","unstructured":"Kennedy BK, Partridge L. 2nd interventions in aging conference. Aging (Albany NY). 2017;9:1090\u20135.","journal-title":"Aging (Albany NY)"},{"key":"2099_CR44","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care. Committee Opinion No. 653: concerns regarding social media and health issues in adolescents and young adults. Obstet Gynecol. 2016;127:e62\u20135.","DOI":"10.1097\/AOG.0000000000001313"},{"key":"2099_CR45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/07420528.2018.1563094","volume":"36","author":"DM McMahon","year":"2019","unstructured":"McMahon DM, Burch JB, Youngstedt SD, Wirth MD, Hardin JW, Hurley TG, et al. Relationships between chronotype, social jetlag, sleep, obesity and blood pressure in healthy young adults. Chronobiol Int. 2019;36:493\u2013509.","journal-title":"Chronobiol Int"},{"key":"2099_CR46","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25:6053\u201362.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02099-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T17:07:43Z","timestamp":1642007263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02099-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02099-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was a post hoc analysis of the NAGALA cohort, and the data were obtained from the Dryad database. We confirm that all the methods used in this study were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This study was a post hoc analysis of the NAGALA cohort, and the submitted materials did not provide any identifying information about the participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"20"}}